73362-100-01 |
73362-100 |
HUMAN PRESCRIPTION DRUG |
Yorvipath |
Palopegteriparatide |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20240809 |
N/A |
NDA |
NDA216490 |
Ascendis Pharma, Endocrinology, Inc. |
PALOPEGTERIPARATIDE |
168 ug/.56mL |
2 BOX in 1 CARTON (73362-100-01) / 1 SYRINGE in 1 BOX (73362-100-02) / 1 CARTRIDGE in 1 SYRINGE (73362-100-03) / .56 mL in 1 CARTRIDGE |
73362-101-01 |
73362-101 |
HUMAN PRESCRIPTION DRUG |
Yorvipath |
Palopegteriparatide |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20240809 |
N/A |
NDA |
NDA216490 |
Ascendis Pharma, Endocrinology, Inc. |
PALOPEGTERIPARATIDE |
294 ug/.98mL |
2 BOX in 1 CARTON (73362-101-01) / 1 SYRINGE in 1 BOX (73362-101-02) / 1 CARTRIDGE in 1 SYRINGE (73362-101-03) / .98 mL in 1 CARTRIDGE |
73362-102-01 |
73362-102 |
HUMAN PRESCRIPTION DRUG |
Yorvipath |
Palopegteriparatide |
INJECTION, SOLUTION |
SUBCUTANEOUS |
20240809 |
N/A |
NDA |
NDA216490 |
Ascendis Pharma, Endocrinology, Inc. |
PALOPEGTERIPARATIDE |
420 ug/1.4mL |
2 BOX in 1 CARTON (73362-102-01) / 1 SYRINGE in 1 BOX (73362-102-02) / 1 CONTAINER in 1 SYRINGE (73362-102-03) / 1.4 mL in 1 CONTAINER |